Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
100.87 USD | -2.26% | +2.72% | +18.20% |
04/12 | Powell tees up after S.Korea jars, France waits | RE |
03/12 | Wall St at records as Paris simmers, yuan hits 2024 low | RE |
Fiscal Period: August | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 2.14TCr | 2.77TCr | 3.08TCr | 1.55TCr | 2.51TCr | |||||
Total Revenues | 2.14TCr | 2.77TCr | 3.08TCr | 1.55TCr | 2.51TCr | |||||
Cost of Goods Sold, Total | 1.49TCr | 1.72TCr | 1.69TCr | 1.7TCr | 1.95TCr | |||||
Gross Profit | 655.2Cr | 1.05TCr | 1.39TCr | -141.6Cr | 561.3Cr | |||||
Selling General & Admin Expenses, Total | 88Cr | 89Cr | 106.6Cr | 92Cr | 112.9Cr | |||||
Stock-Based Compensation (IS) | - | - | - | - | - | |||||
R&D Expenses | 260Cr | 266.3Cr | 311.6Cr | 311.4Cr | 343Cr | |||||
Other Operating Expenses | 1.1Cr | 12Cr | 70L | 90L | -19Cr | |||||
Other Operating Expenses, Total | 349.2Cr | 367.6Cr | 418.9Cr | 404.3Cr | 436.7Cr | |||||
Operating Income | 306Cr | 679.6Cr | 970.9Cr | -545.9Cr | 124.6Cr | |||||
Interest Expense, Total | -19Cr | -18Cr | -19Cr | -39Cr | -56Cr | |||||
Interest And Investment Income | 11Cr | 3.7Cr | 9.6Cr | 47Cr | 53Cr | |||||
Net Interest Expenses | -8Cr | -15Cr | -9.3Cr | 8Cr | -3.3Cr | |||||
Income (Loss) On Equity Invest. | 70L | 3.7Cr | 40L | 20L | -1.1Cr | |||||
Currency Exchange Gains (Loss) | -80L | - | - | - | - | |||||
Other Non Operating Income (Expenses) | 2.8Cr | - | 1.9Cr | 1.5Cr | 10L | |||||
EBT, Excl. Unusual Items | 300.7Cr | 668.7Cr | 963.9Cr | -536.2Cr | 120.3Cr | |||||
Restructuring Charges | 1.1Cr | -54Cr | -4.8Cr | -17Cr | -10L | |||||
Merger & Related Restructuring Charges | - | - | - | - | - | |||||
Impairment of Goodwill | - | - | - | -10Cr | - | |||||
Gain (Loss) On Sale Of Investments | - | 8.2Cr | 2.6Cr | -80L | -3.2Cr | |||||
Gain (Loss) On Sale Of Assets | 30L | 2.4Cr | 4.1Cr | 5.4Cr | 5.9Cr | |||||
Asset Writedown | -7.1Cr | - | - | - | - | |||||
Legal Settlements | - | - | - | -6.8Cr | - | |||||
Other Unusual Items | 4Cr | -10L | -8.3Cr | - | - | |||||
EBT, Incl. Unusual Items | 299Cr | 625.5Cr | 957.5Cr | -565.6Cr | 122.9Cr | |||||
Income Tax Expense | 28Cr | 39Cr | 89Cr | 18Cr | 45Cr | |||||
Earnings From Continuing Operations | 271Cr | 586.1Cr | 868.7Cr | -583.3Cr | 78Cr | |||||
Net Income to Company | 271Cr | 586.1Cr | 868.7Cr | -583.3Cr | 78Cr | |||||
Minority Interest | -2.3Cr | - | - | - | - | |||||
Net Income - (IS) | 268.7Cr | 586.1Cr | 868.7Cr | -583.3Cr | 78Cr | |||||
Net Income to Common Incl Extra Items | 268.7Cr | 586.1Cr | 868.7Cr | -583.3Cr | 78Cr | |||||
Net Income to Common Excl. Extra Items | 268.7Cr | 586.1Cr | 868.7Cr | -583.3Cr | 78Cr | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 2.42 | 5.23 | 7.81 | -5.34 | 0.7 | |||||
Basic EPS - Continuing Operations | 2.42 | 5.23 | 7.81 | -5.34 | 0.7 | |||||
Basic Weighted Average Shares Outstanding | 111Cr | 112Cr | 111.2Cr | 109.3Cr | 110.5Cr | |||||
Net EPS - Diluted | 2.37 | 5.14 | 7.75 | -5.34 | 0.7 | |||||
Diluted EPS - Continuing Operations | 2.37 | 5.14 | 7.75 | -5.34 | 0.7 | |||||
Diluted Weighted Average Shares Outstanding | 113.1Cr | 114.1Cr | 112.2Cr | 109.3Cr | 111.8Cr | |||||
Normalized Basic EPS | 1.67 | 3.73 | 5.42 | -3.07 | 0.68 | |||||
Normalized Diluted EPS | 1.64 | 3.66 | 5.37 | -3.07 | 0.67 | |||||
Dividend Per Share | - | 0.1 | 0.43 | 0.46 | 0.46 | |||||
Payout Ratio | - | - | 5.31 | -8.64 | 65.94 | |||||
American Depositary Receipts Ratio (ADR) | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | |||||
Supplemental Items | ||||||||||
EBITDA | 871Cr | 1.3TCr | 1.68TCr | 221.1Cr | 894.4Cr | |||||
EBITA | 306Cr | 679.6Cr | 970.9Cr | -545.9Cr | 124.6Cr | |||||
EBIT | 306Cr | 679.6Cr | 970.9Cr | -545.9Cr | 124.6Cr | |||||
EBITDAR | 881.2Cr | 1.31TCr | 1.7TCr | 234.8Cr | 908.4Cr | |||||
Effective Tax Rate - (Ratio) | 9.36 | 6.3 | 9.27 | -3.13 | 36.7 | |||||
Current Domestic Taxes | 2.2Cr | 4.3Cr | 6.6Cr | 60L | 8.3Cr | |||||
Current Foreign Taxes | 15Cr | 37Cr | 53Cr | 18Cr | 33Cr | |||||
Total Current Taxes | 17Cr | 41Cr | 59Cr | 18Cr | 42Cr | |||||
Deferred Domestic Taxes | -6.2Cr | -1.9Cr | 39Cr | 8.4Cr | -1.8Cr | |||||
Deferred Foreign Taxes | 17Cr | - | -9.7Cr | -9.1Cr | 5.3Cr | |||||
Total Deferred Taxes | 11Cr | -1.9Cr | 29Cr | -70L | 3.5Cr | |||||
Normalized Net Income | 185.64Cr | 417.94Cr | 602.44Cr | -335.12Cr | 75Cr | |||||
Interest Capitalized | 7.7Cr | 6.6Cr | 7.7Cr | 21Cr | 22Cr | |||||
Interest on Long-Term Debt | 11Cr | 8.6Cr | 10Cr | 23Cr | 30Cr | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 260Cr | 266.3Cr | 311.6Cr | 311.4Cr | 343Cr | |||||
Net Rental Expense, Total | 10Cr | 11Cr | 12Cr | 14Cr | 14Cr | |||||
Imputed Operating Lease Interest Expense | 3.38Cr | 2.95Cr | 3.57Cr | 6.06Cr | 6.28Cr | |||||
Imputed Operating Lease Depreciation | 6.82Cr | 7.85Cr | 8.93Cr | 7.64Cr | 7.72Cr | |||||
Stock-Based Comp., COGS (Total) | 14Cr | 19Cr | 19Cr | 20Cr | 31Cr | |||||
Stock-Based Comp., R&D Exp. (Total) | 8.6Cr | 11Cr | 18Cr | 23Cr | 30Cr | |||||
Stock-Based Comp., SG&A Exp. (Total) | 10Cr | 9.9Cr | 13Cr | 14Cr | 21Cr | |||||
Stock-Based Comp., Other (Total) | - | - | - | 3.2Cr | 1.2Cr | |||||
Total Stock-Based Compensation | 33Cr | 40Cr | 50Cr | 60Cr | 83Cr |